论文部分内容阅读
急性肺血栓栓塞症(APE)是由于血栓性栓子堵塞肺动脉及其分支而引起的以肺循环功能和呼吸功能障碍为主要表现的临床和病理生理综合征。APE的临床表现复杂多变,缺乏特异性,误诊、误治率较高,目前主要依赖于CT肺动脉造影(CTPA)、肺血管造影(PA)等影像学或有创性操作确诊。但上述诊查措施存在着步骤繁琐、无法床边实施和造影剂过敏等不足,为此能否通过生物学标志物快速对APE进
Acute pulmonary thromboembolism (APE) is a clinical and pathophysiological syndrome mainly characterized by pulmonary circulation and respiratory dysfunction due to the blockage of the pulmonary artery and its branches by thrombus emboli. The clinical manifestations of APE are complicated and variable, lack of specificity, misdiagnosis and high false-positive rate. Currently, APE is mainly confirmed by imaging or invasive procedures such as CT pulmonary angiography (CTPA) and pulmonary angiography (PA). However, the above diagnostic measures exist tedious steps, the bedside can not be implemented and contrast agents and other shortcomings, for the rapid adoption of biomarkers APE into